Recent News

• 03.19.2026 - Grace Therapeutics to Present Data on the Unmet Medical Needs and Potential Benefits of GTx-104 in the Treatment of aSAH at Upcoming Medical Conferences
• 02.25.2026 - Grace Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference
• 02.12.2026 - Grace Therapeutics Announces Third Quarter 2026 Financial Results, Provides Business Update
• 11.17.2025 - Grace Therapeutics to Participate in 16th Annual Craig-Hallum Alpha Select Conference
• 11.13.2025 - Grace Therapeutics Announces Second Quarter 2026 Financial Results, Provides Business Update

Recent Filings

• 02.17.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.13.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.12.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 02.12.2026 - 8-K Current report
• 02.12.2026 - EX-99.1 EX-99.1
• 01.28.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 01.12.2026 - 8-K Current report
• 01.12.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.12.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.12.2026 - 4 Statement of changes in beneficial ownership of securities